ExpressionEdits

About:

ExpressionEdits is a biotechnology company that redesigns synthetic DNA instructions using AI, focusing on protein expression.

Website: https://www.expressionedits.com

Twitter/X: expressionedits

Top Investors: Octopus Ventures, redalpine, BlueYard Capital, Acequia Capital (AceCap), Hawktail Management

Description:

ExpressionEdits operates in the biotechnology industry, focusing on the redesign of synthetic DNA instructions. The company utilizes an AI-driven approach to redefine the status quo of protein expression. It is involved in building biology similar to nature. The team at ExpressionEdits includes scientists and engineers who are dedicated to developing new technologies. Proteins, a foundational pillar in healthcare and behind every major advancement in biotech and synthetic biology, are at the core of their work.

Total Funding Amount:

$13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Haverhill, Suffolk, United Kingdom

Founded Date:

2021-01-01

Contact Email:

hello(AT)expressionedits.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-05-29

IPO Status:

Private

© 2024 MyAiNote.com